SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about analyst meet

12 Sep 2018 Evaluate

Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, Neuland Laboratories has informed about the details of the Analyst/Institutional Investor meeting on September 11, 2018, at Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

16962.05 29.40 (0.17%)
11-Jun-2026 15:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.40
Dr. Reddys Lab 1278.70
Cipla 1385.00
Zydus Lifesciences 1105.80
Lupin 2273.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: